174 related articles for article (PubMed ID: 22389255)
21. Transcriptional activation of the human CD2AP promoter by E2F1.
Zou L; Xu HG; Ren W; Jin R; Wang Y; Zhou GP
PLoS One; 2012; 7(8):e42774. PubMed ID: 22880102
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3.
Mussi P; Yu C; O'Malley BW; Xu J
Mol Endocrinol; 2006 Dec; 20(12):3105-19. PubMed ID: 16916939
[TBL] [Abstract][Full Text] [Related]
23. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
[TBL] [Abstract][Full Text] [Related]
24. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of human fibroblast growth factor receptor 1 by E2F-1.
Kanai M; Tashiro E; Maruki H; Minato Y; Imoto M
Gene; 2009 Jun; 438(1-2):49-56. PubMed ID: 19303924
[TBL] [Abstract][Full Text] [Related]
26. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
[TBL] [Abstract][Full Text] [Related]
27. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
28. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.
Zhou C; Wawrowsky K; Bannykh S; Gutman S; Melmed S
Mol Endocrinol; 2009 Dec; 23(12):2000-12. PubMed ID: 19837943
[TBL] [Abstract][Full Text] [Related]
29. Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter.
De Luca A; Sacchetta P; Nieddu M; Di Ilio C; Favaloro B
BMC Mol Biol; 2007 May; 8():39. PubMed ID: 17519015
[TBL] [Abstract][Full Text] [Related]
30. E2F1 contributes to the transcriptional activation of the KIR3DL1 gene.
Gao XN; Yu L
Biochem Biophys Res Commun; 2008 Jun; 370(3):399-403. PubMed ID: 18358829
[TBL] [Abstract][Full Text] [Related]
31. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A
Cancer Cell; 2006 Jun; 9(6):459-71. PubMed ID: 16766265
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
33. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
34. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
36. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.
D'Angelo D; Palmieri D; Mussnich P; Roche M; Wierinckx A; Raverot G; Fedele M; Croce CM; Trouillas J; Fusco A
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1128-38. PubMed ID: 22564666
[TBL] [Abstract][Full Text] [Related]
37. Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation.
Pillai S; Kovacs M; Chellappan S
Cancer Res; 2010 Jun; 70(12):4931-40. PubMed ID: 20516113
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers.
Onda M; Nagai H; Yoshida A; Miyamoto S; Asaka SI; Akaishi J; Takatsu K; Nagahama M; Ito K; Shimizu K; Emi M
J Hum Genet; 2004; 49(6):312-318. PubMed ID: 15118916
[TBL] [Abstract][Full Text] [Related]
39. Activating E2Fs mediate transcriptional regulation of human E2F6 repressor.
Lyons TE; Salih M; Tuana BS
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C189-99. PubMed ID: 16107498
[TBL] [Abstract][Full Text] [Related]
40. microRNA‑202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN‑5.
Li YG; He JH; Yu L; Hang ZP; Li W; Shun WH; Huang GX
Mol Med Rep; 2014 Feb; 9(2):541-6. PubMed ID: 24337320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
